Clinical Trial Update: North American Study for the Treatment of Refractory Ascites (NASTRA) [Phase 3]

View source ↗

Summary

The North American Study for the Treatment of Refractory Ascites (NASTRA), a Phase 3 trial sponsored by the NIDDK, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Liver Cirrhosis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Ascites, Liver Cirrhosis | Phase 3 | Status: COMPLETED